{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:36:15Z","timestamp":1791333375205,"version":"4.3.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.msard.2022.104466","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T09:39:49Z","timestamp":1670751589000},"page":"104466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A novel association of osmotic demyelination in Sj\u00f6gren's syndrome prompts revisiting role of aquaporins in CNS demyelinating diseases: A literature review"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-4535","authenticated-orcid":false,"given":"Pulukool","family":"Sandhya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Akaishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2022.104466_bib0001","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archneurpsyc.1959.02340140020004","article-title":"Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients","volume":"81","author":"Adams","year":"1959","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"10.1016\/j.msard.2022.104466_bib0002","doi-asserted-by":"crossref","first-page":"iii22","DOI":"10.1136\/jnnp.2004.045906","article-title":"Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes","volume":"75","author":"Martin","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.msard.2022.104466_bib0003","first-page":"600","article-title":"Central Pontine Myelinosis and Osmotic Demyelination Syndrome","volume":"116","author":"Lambeck","year":"2019","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"10.1016\/j.msard.2022.104466_bib0004","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0002-9343(94)90166-X","article-title":"Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia","volume":"96","author":"Lohr","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.msard.2022.104466_bib0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sj\u00f6gren's syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2022.104466_bib0006","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.msard.2022.104466_bib0007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1874312901408010103","article-title":"Sj\u00f6gren's, Renal Tubular Acidosis And Osteomalacia - An Asian Indian Series","volume":"8","author":"Sandhya","year":"2014","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.msard.2022.104466_bib0008","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sj\u00f6gren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"Ramos-Casals","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.msard.2022.104466_bib0009","article-title":"Comprehensive analysis of clinical and laboratory features of 440 published cases of Sj\u00f6gren's syndrome and renal tubular acidosis","author":"Sandhya","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.msard.2022.104466_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577236","article-title":"Risk factors of attacks in neuromyelitis optica spectrum disorders","volume":"343","author":"Akaishi","year":"2020","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.msard.2022.104466_bib0011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11926-021-01000-2","article-title":"Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist","volume":"23","author":"Cruz","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.msard.2022.104466_bib0012","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.104466_bib0013","first-page":"1240","article-title":"A patient with Sj\u00f6gren syndrome with central pontine myelinolysis and hypokalemic myopathy","volume":"36","author":"Nagashima","year":"1996","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.msard.2022.104466_bib0014","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/096120300678828550","article-title":"Central pontine myelinolysis\u2013a rare manifestation of CNS Sjogren's syndrome","volume":"9","author":"Yoon","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.msard.2022.104466_bib0015","first-page":"502","article-title":"Hyperammoniemia and central pontine myelinolysis in a patient with Sj\u00f6gren syndrome and chronic valproate use","volume":"99","author":"Berlot","year":"2008","journal-title":"Recenti Prog Med"},{"issue":"suppl_1","key":"10.1016\/j.msard.2022.104466_bib0016","first-page":"i20","article-title":"A Case of Sjogren's Syndrome with Renal Tubular Acidosis and Central Pontine Myelinolysis Concurrent Oral 9 \u2013 Case Reports [OP55\u2013OP62]","volume":"48","author":"Watson","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.msard.2022.104466_bib0017","first-page":"215","article-title":"[Central pontine myelinolysis in Sjogren's syndrome]","volume":"88","author":"Naziha","year":"2010","journal-title":"Tunis Med"},{"key":"10.1016\/j.msard.2022.104466_bib0018","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/j.1756-185X.2011.01636.x","article-title":"A combination of extraglandular manifestations of Sj\u00f6gren's syndrome","volume":"15","author":"Cheah","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.msard.2022.104466_bib0019","doi-asserted-by":"crossref","first-page":"058","DOI":"10.5606\/tjr.2013.2713","article-title":"Primary Sjogren's Syndrome Presenting with Renal Tubular Acidosis and Central Pontine Myelinolysis: A Case Report","volume":"28","author":"Rubo","year":"2013","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.msard.2022.104466_bib0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2369-15-56","article-title":"Plasma exchange successfully treats central pontine myelinolysis after acute hypernatremia from intravenous sodium bicarbonate therapy","volume":"15","author":"Chang","year":"2014","journal-title":"BMC Nephrol"},{"issue":"8","key":"10.1016\/j.msard.2022.104466_bib0021","first-page":"274","article-title":"Primary Sjogren's Syndrome with Renal Tubular Acidosis with Central Pontine Myelinolysis - A rare case report","volume":"3","author":"Saxena","year":"2016","journal-title":"IAIM"},{"key":"10.1016\/j.msard.2022.104466_bib0022","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/1756-185X.12847","article-title":"Central pontine myelinolysis in Sjogren's syndrome with hypokalemia","volume":"20","author":"Abdulla","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.msard.2022.104466_bib0023","first-page":"46","article-title":"Central pontine and extrapontine myelinolysis induced by severe hypokalemia, a rare manifestation of Sj\u00f6gren's syndrome","volume":"4","author":"Mellat","year":"2016","journal-title":"Journal of Case Reports in Practice"},{"key":"10.1016\/j.msard.2022.104466_bib0024","first-page":"1807","article-title":"Central pontine and extrapontine myelinolysis in girl with sj\u00f6gren's syndrome","volume":"33","author":"Aksenova","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.msard.2022.104466_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.548877","article-title":"Unusual Presentation of Polyautoimmunity and Renal Tubular Acidosis in an Adolescent With Hashimoto's Thyroiditis and Central Pontine Myelinolysis","volume":"11","author":"Bruns","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.msard.2022.104466_bib0026","first-page":"e19644","article-title":"Rare Case of Central Pontine Myelinolysis: Etiological Dilemma","volume":"13","author":"Maturu","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.msard.2022.104466_bib0027","first-page":"1039","article-title":"Quadriplegia, due to hypokalaemia and related osmotic demyelination syndrome, as an initial presentation of Sjogren's syndrome","volume":"2","author":"Paul","year":"2022","journal-title":"J Clin Med Surgery"},{"key":"10.1016\/j.msard.2022.104466_bib0028","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2177\/jsci.10.207","article-title":"Aseptic meningoencephalitis in Sj\u00f6gren's syndrome","volume":"10","author":"Taneichi","year":"1987","journal-title":"Jpn J Clin Immunol"},{"key":"10.1016\/j.msard.2022.104466_bib0029","doi-asserted-by":"crossref","DOI":"10.29046\/TMF.017.1.016","article-title":"Distal Renal Tubular Acidosis and Diabetes Insipidus Leading to the Diagnosis Of Sj\u00f6gren's Syndrome","volume":"17","author":"Ragupathi","year":"2016","journal-title":"Med Forum"},{"key":"10.1016\/j.msard.2022.104466_bib0030","first-page":"158","article-title":"Onset of primary Sj\u00f6gren syndrome with mitochondrial polymyositis, axonal neuropathy, and hypokalaemic paralysis: Case report","volume":"27","author":"Garc\u00eda-Alfonso","year":"2020","journal-title":"Rev Colomb Reumatol"},{"key":"10.1016\/j.msard.2022.104466_bib0031","article-title":"Topiramate-induced severe electrolyte abnormalities and hypernatremia leading to central pontine myelinolysis","volume":"14","author":"Muaddi","year":"2021","journal-title":"BMJ Case Rep CP"},{"key":"10.1016\/j.msard.2022.104466_bib0032","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/oxfordjournals.ndt.a027683","article-title":"A chronic glue sniffer with hyperchloraemia metabolic acidosis, rhabdomyolysis, irreversible quadriplegia, central pontine myelinolysis, and hypothyroidism","volume":"11","author":"Hong","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.msard.2022.104466_bib0033","first-page":"1061","article-title":"Pontine hemorrhage in a patient with type 1 renal tubular acidosis associated with osmotic demyelination syndrome","volume":"60","author":"Hoshino","year":"2008","journal-title":"Brain Nerve Shinkei Kenkyu No Shinpo"},{"key":"10.1016\/j.msard.2022.104466_bib0034","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5692\/clinicalneurol.50.168","article-title":"Neuromyelitis optica in a patient with Sj\u00f6gren syndrome with distal renal tubular acidosis: case report","volume":"50","author":"Imbe","year":"2010","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.msard.2022.104466_bib0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4103\/0972-5229.164808","article-title":"An unusually dry story","volume":"19","author":"Rajagopala","year":"2015","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.msard.2022.104466_bib0036","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/0961203319877255","article-title":"Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience","volume":"28","author":"Mart\u00edn-Nares","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.msard.2022.104466_bib0037","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.3174\/ajnr.A3392","article-title":"Clinical Semiology and Neuroradiologic Correlates of Acute Hypernatremic Osmotic Challenge in Adults: A Literature Review","volume":"34","author":"Ismail","year":"2013","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.msard.2022.104466_bib0038","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2005.01.008","article-title":"Causes of reversible nephrogenic diabetes insipidus: a systematic review","volume":"45","author":"Garofeanu","year":"2005","journal-title":"Am J Kidney"},{"key":"10.1016\/j.msard.2022.104466_bib0039","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1258\/acb.2009.009094","article-title":"Central pontine myelinolysis secondary to hypokalaemic nephrogenic diabetes insipidus","volume":"47","author":"Davenport","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.msard.2022.104466_bib0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5414\/CNP67345","article-title":"Centropontine myelinolysis after correction of hyponatremia: role of associated hypokalemia","volume":"67","author":"Heng","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.msard.2022.104466_bib0041","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jnnp.2009.201764","article-title":"Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and\/or extrapontine myelinolysis) in 25 patients","volume":"82","author":"Kallakatta","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.msard.2022.104466_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.654865","article-title":"Human Aquaporins: Functional Diversity and Potential Roles in Infectious and Non-infectious Diseases","volume":"12","author":"Azad","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.msard.2022.104466_bib0043","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.3390\/ijms17020166","article-title":"Aquaporins in Salivary Glands: From Basic Research to Clinical Applications","volume":"17","author":"Delporte","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.msard.2022.104466_bib0044","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.3390\/ijms19113392","article-title":"Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sj\u00f6gren's Syndrome","volume":"19","author":"Soyfoo","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.msard.2022.104466_bib0045","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/01.LAB.0000038502.42845.9E","article-title":"Selective Down-Regulation of Aquaporin-1 in Salivary Glands in Primary Sj\u00f6gren's Syndrome","volume":"82","author":"Beroukas","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.msard.2022.104466_bib0046","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/08916934.2017.1341495","article-title":"Abnormal distribution of AQP4 in minor salivary glands of primary Sj\u00f6gren's syndrome patients","volume":"50","author":"Sisto","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.msard.2022.104466_bib0047","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/labinvest.3780221","article-title":"Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sj\u00f6gren's syndrome patients","volume":"81","author":"Steinfeld","year":"2001","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"10.1016\/j.msard.2022.104466_bib0048","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/art.22826","article-title":"Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy","volume":"56","author":"Soyfoo","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.msard.2022.104466_bib0049","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/14397595.2015.1083146","article-title":"Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sj\u00f6gren's syndrome including neuromyelitis optica complicated patients","volume":"26","author":"Yoshimura","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.msard.2022.104466_bib0050","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/j.1582-4934.2011.01456.x","article-title":"TNF-\u03b1 inhibits aquaporin 5 expression in human salivary gland acinar cells via suppression of histone H4 acetylation","volume":"16","author":"Yamamura","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.msard.2022.104466_bib0051","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2353\/ajpath.2010.090282","article-title":"Potential down-regulation of salivary gland AQP5 by LPS via cross-coupling of NF-kappaB and p-c-Jun\/c-Fos","volume":"177","author":"Yao","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.msard.2022.104466_bib0052","doi-asserted-by":"crossref","first-page":"e53113","DOI":"10.1371\/journal.pone.0053113","article-title":"Autoantibodies against muscarinic type 3 receptor in Sj\u00f6gren's syndrome inhibit aquaporin 5 trafficking","volume":"8","author":"Lee","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.msard.2022.104466_bib0053","doi-asserted-by":"crossref","first-page":"9213","DOI":"10.3390\/ijms22179213","article-title":"Ezrin Is a Novel Protein Partner of Aquaporin-5 in Human Salivary Glands and Shows Altered Expression and Cellular Localization in Sj\u00f6gren's Syndrome","volume":"22","author":"Chivasso","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.msard.2022.104466_bib0054","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.3390\/cells10082108","article-title":"Unraveling Human AQP5-PIP Molecular Interaction and Effect on AQP5 Salivary Glands Localization in SS Patients","volume":"10","author":"Chivasso","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.msard.2022.104466_bib0055","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s12026-016-8786-x","article-title":"Detection of autoantibodies against aquaporin-5 in the sera of patients with primary Sj\u00f6gren's syndrome","volume":"64","author":"Alam","year":"2016","journal-title":"Immunol Res"},{"key":"10.1016\/j.msard.2022.104466_bib0056","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4110\/in.2017.17.2.103","article-title":"Detection of Autoantibodies against Aquaporin-1 in the Sera of Patients with Primary Sj\u00f6gren's Syndrome","volume":"17","author":"Alam","year":"2017","journal-title":"Immune Netw"},{"key":"10.1016\/j.msard.2022.104466_bib0057","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/rheumatology\/kex328","article-title":"Antibodies to aquaporins are frequent in patients with primary Sj\u00f6gren's syndrome","volume":"56","author":"Tzartos","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.msard.2022.104466_bib0058","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3390\/jcm8111863","article-title":"Associations of Anti-Aquaporin 5 Autoantibodies with Serologic and Histopathological Features of Sj\u00f6gren's Syndrome","volume":"8","author":"Jeon","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.msard.2022.104466_bib0059","doi-asserted-by":"crossref","first-page":"F193","DOI":"10.1152\/ajprenal.00304.2019","article-title":"Aquaporins in the kidney: physiology and pathophysiology","volume":"318","author":"Su","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.msard.2022.104466_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep18311","article-title":"Autophagic degradation of aquaporin-2 is an early event in hypokalemia-induced nephrogenic diabetes insipidus","volume":"5","author":"Khositseth","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.msard.2022.104466_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1134\/S1819712420010171","article-title":"Functional Role of Aquaporins in the Nervous System under Normal and Pathological Conditions","volume":"14","author":"Shchepareva","year":"2020","journal-title":"Neurochem J"},{"key":"10.1016\/j.msard.2022.104466_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.767470","article-title":"Cerebral Microcirculation, Perivascular Unit, and Glymphatic System: Role of Aquaporin-4 as the Gatekeeper for Water Homeostasis","volume":"12","author":"Szczygielski","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.msard.2022.104466_bib0063","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1152\/physrev.00011.2013","article-title":"Physiological roles of aquaporin-4 in brain","volume":"93","author":"Nagelhus","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.msard.2022.104466_bib0064","doi-asserted-by":"crossref","first-page":"e34936","DOI":"10.1371\/journal.pone.0034936","article-title":"Potassium Dependent Regulation of Astrocyte Water Permeability Is Mediated by cAMP Signaling","volume":"7","author":"Song","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msard.2022.104466_bib0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2051-5960-1-40","article-title":"Evidence of aquaporin involvement in human central pontine myelinolysis","volume":"1","author":"Popescu","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.msard.2022.104466_bib0066","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.12659\/MSM.907212","article-title":"Hypertonic Saline Alleviates Brain Edema After Traumatic Brain Injury via Downregulation of Aquaporin 4 in Rats","volume":"24","author":"Yin","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.msard.2022.104466_bib0067","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neuroscience.2009.12.076","article-title":"Hypertonic saline ameliorates cerebral edema through downregulation of aquaporin-4 expression in the astrocytes","volume":"166","author":"Zeng","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.msard.2022.104466_bib0068","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1212\/NXI.0000000000000110","article-title":"Aquaporin-4 autoimmunity","volume":"2","author":"Zekeridou","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.msard.2022.104466_bib0069","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.msard.2022.104466_bib0070","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/archneurol.2009.188","article-title":"Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells","volume":"66","author":"Hinson","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.msard.2022.104466_bib0071","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00401-017-1734-6","article-title":"Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica","volume":"134","author":"Tradtrantip","year":"2017","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.msard.2022.104466_bib0072","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.biocel.2012.06.013","article-title":"Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies","volume":"44","author":"Ratelade","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.msard.2022.104466_bib0073","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1212\/WNL.0000000000012175","article-title":"Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder","volume":"97","author":"Akaishi","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.104466_bib0074","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.0b013e3181a82621","article-title":"A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset","volume":"72","author":"Nishiyama","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.104466_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103494","article-title":"Clinical significance of anti-SSA\/Ro antibody in Neuromyelitis optica spectrum disorders","volume":"58","author":"Lin","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2022.104466_bib0076","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jns.2014.11.020","article-title":"Presence of anti-Ro\/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder","volume":"348","author":"Park","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.msard.2022.104466_bib0077","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00415-020-10377-6","article-title":"Impact of comorbid Sj\u00f6gren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders","volume":"268","author":"Akaishi","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.msard.2022.104466_bib0078","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.msard.2022.104466_bib0079","doi-asserted-by":"crossref","first-page":"556","DOI":"10.5692\/clinicalneurol.54.556","article-title":"Case of neuromyelitis optica spectrum disorder associated with central pontine and extrapontine myelinolysis preceded by syndrome of inappropriate antidiuretic hormone secretion","volume":"54","author":"Sakai","year":"2014","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.msard.2022.104466_bib0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.7224\/1537-2073.2016-077","article-title":"Case Report: Osmotic Demyelination Syndrome in an Adolescent with Neuromyelitis Optica","volume":"20","author":"Kariv","year":"2018","journal-title":"Int J MS Care"},{"key":"10.1016\/j.msard.2022.104466_bib0081","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.4103\/jfmpc.jfmpc_1117_19","article-title":"Jaw clonus in neuromyelitis optica spectrum disorder with subsequent osmotic demyelination syndrome","volume":"9","author":"Ghosh","year":"2020","journal-title":"J Fam Med Prim Care"},{"key":"10.1016\/j.msard.2022.104466_bib0082","doi-asserted-by":"crossref","first-page":"e1145","DOI":"10.1097\/MD.0000000000001145","article-title":"The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article","volume":"94","author":"Qiao","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.msard.2022.104466_bib0083","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sj\u00f6gren's syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.msard.2022.104466_bib0084","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/acr.23107","article-title":"The Relationship Between the Neuromyelitis Optica Spectrum Disorder and Sj\u00f6gren's Syndrome: Central Nervous System Extraglandular Disease or Unrelated, Co-occurring Autoimmunity?","volume":"69","author":"Birnbaum","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.msard.2022.104466_bib0085","doi-asserted-by":"crossref","first-page":"e74773","DOI":"10.1371\/journal.pone.0074773","article-title":"Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders","volume":"8","author":"Tzartos","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.msard.2022.104466_bib0086","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome: A consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822009701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822009701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:06:09Z","timestamp":1761901569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822009701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":86,"alternative-id":["S2211034822009701"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.104466","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel association of osmotic demyelination in Sj\u00f6gren's syndrome prompts revisiting role of aquaporins in CNS demyelinating diseases: A literature review","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.104466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104466"}}